ALA-Porphyrin Science

投稿規定

icon_docJapanese_Version.doc

icon_docEnglish_Version.doc

Vol.11 No.1, 2022

Adverse effect of repeated treatment with 5-aminoleveuic acid in healthy cats and those with chronic kidney disease
Reo Nishi, Mona Uchida, Masato Nakahara, Shingo Maeda, Akio Hayashi, Nao Iwatani, Toru Tanaka and Tomohiro Yonezawa
icon_pdf2022-1.pdf

Vol.10 No.1, 2021

Phase 2 randomized clinical trial of 5-Aminolevulinic acid plus sodium citrate chloride vs placebo for Covid-19 infected patients recovered with sequelae
Kyoko Imamura, Hidemitsu Sugihara and Koichi Hirahata
icon_pdf2021_2.pdf

Enhancing Effect of Novel Schiff Base Derivatives, UTX-134 and UTX-135, on 5-Aminolevulinic Acid-based Photodynamic Therapy
Hirari Yamahana, Yusei Shinohara, Yoshio Endo, Tohru Obata, Hisatsugu Yamada and Yoshihiro Uto
icon_pdf2021_1.pdf

ALA and Porphyrin Research Society